Artivion (AORT) Total Current Liabilities (2010 - 2026)
Artivion (AORT) posted Total Current Liabilities of $92.7 million for Q1 2026, down 8.72% on a QoQ basis from $101.6 million in Q4 2025, and up 78.48% year-over-year from $51.9 million in Q1 2025.
Artivion (AORT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Artivion's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $92.7 million for Q1 2026.
- Quarterly Total Current Liabilities rose 78.48% year-over-year to $92.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.7 million (up 78.48% YoY) and the FY2025 annual result came in at $101.6 million, up 51.98% from the prior year.
- Total Current Liabilities was $92.7 million for Q1 2026 at Artivion, down from $101.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $152.8 million in Q3 2024 and bottomed at $41.6 million in Q2 2022.
- A 5-year average of $65.2 million and a median of $55.0 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 178.09% — and 2025, when it tumbled 43.84%.
- Artivion's Total Current Liabilities stood at $49.7 million in 2022, then advanced by 16.48% to $57.9 million in 2023, then advanced by 15.49% to $66.8 million in 2024, then surged by 51.98% to $101.6 million in 2025, then dropped by 8.72% to $92.7 million in 2026.
- Business Quant data shows AORT's Total Current Liabilities at $92.7 million in Q1 2026, $101.6 million in Q4 2025, and $85.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 92.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.70 Mn |
| Dec 31, 2025 | 101.56 Mn |
| Sep 30, 2025 | 85.84 Mn |
| Jun 30, 2025 | 66.67 Mn |
| Mar 31, 2025 | 51.94 Mn |
| Dec 31, 2024 | 66.82 Mn |
| Sep 30, 2024 | 152.84 Mn |
| Jun 30, 2024 | 50.58 Mn |
| Mar 31, 2024 | 45.83 Mn |
| Dec 31, 2023 | 57.86 Mn |
| Sep 30, 2023 | 54.96 Mn |
| Jun 30, 2023 | 56.23 Mn |
| Mar 31, 2023 | 43.96 Mn |
| Dec 31, 2022 | 49.68 Mn |
| Sep 30, 2022 | 45.99 Mn |
| Jun 30, 2022 | 41.65 Mn |
| Mar 31, 2022 | 42.84 Mn |
| Dec 31, 2021 | 44.95 Mn |
| Sep 30, 2021 | 61.13 Mn |
| Jun 30, 2021 | 58.94 Mn |